Next Gen | LED Lighting
Next Gen Illumination
Next Gen Illumination, Inc. (NGI), has built its business by designing, distributing and marketing LED lighting products with focus on high-tech R&D, strategic partnerships and multi-tiered sales networks.
Incorporated in April, 2008, NGI has gone to market by developing products that are industry specific, yet have broader market applications. NGI is targeting specific industries in agriculture, manufacturing, and commercial facilities through design and development of products built around NGI patented and patent pending technology.
Penetrating these specific niche industries provides the best combination of versatility and speed to market. NGI has secured customers and partners throughout the world in each piece of the value chain - science, research, technology, design, development, supply, manufacturing, influence, marketing and sales.
These relationships ensure NGI’s ability to provide the best solutions from around the world. Northwest Arkansas currently serves as the center for sales, marketing and administration providing a central location nationally from which to operate.
- Advanced Materials
- 700 W. Research Center Blvd.
- Suite 1000
- Fayetteville, AR 72701
- (479) 521-1177
- (479) 966-4052
- Christopher Callahan - CEO
- Erik Figenskau - President, Director of Sales & Marketing
- Jeffrey Beaver - VP of Research & Development
- Jerry McCormick - Director of Administration
- Patrick Rush - Chief Legal Officer, Director of Media Relations
The partnership with Verizon will enable Aurora clients to use the Verizon Wireless network to power their digital signage and eliminate the need to run internal cables.
Gamers can expect to see the free Overwatch combat gaming app in the iTunes store within a couple of weeks, Overwatch CEO Josh Moody told his 1 Million Cups audience Wednesday in Little Rock.
Joining AVC co-founder, president and CEO Lee Watson on staff are Caroline Ford as director of communications and development and Marshal Kenneday as director of operations. AVC was founded in 2013 and officially launched in May with a $500,000 matching grant from the state.
Researchers at the University of Arkansas have been awarded $1.5 million from the National Cancer Institute at the National Institutes of Health to develop new molecules and biopharmaceuticals that improve a patient's immune response against tumors.